1-17 of 17
Craig L. Slingluff
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer

Lestat R. Ali, Patrick J. Lenehan, Victoire Cardot-Ruffino, Andressa Dias Costa, Matthew H.G. Katz, Todd W. Bauer, Jonathan A. Nowak, Brian M. Wolpin, Thomas A. Abrams, Anuj Patel, Thomas E. Clancy, Jiping Wang, Joseph D. Mancias, Matthew J. Reilley, Chee-Chee H. Stucky, Tanios S. Bekaii-Saab, Rawad Elias, Nipun Merchant, Craig L. Slingluff, Jr, Osama E. Rahma, Stephanie K. Dougan
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (3): 542–553.
https://doi.org/10.1158/1078-0432.CCR-23-1444
Published: 01 February 2024
View articletitled, PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer
Open the PDF for PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer in another window
Includes: Supplementary data
Journal Articles

Building on the Promise of Cancer Vaccines for Solid Tumors

Craig L. Slingluff, Jr
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (3): 529–531.
https://doi.org/10.1158/1078-0432.CCR-19-3206
Published: 03 February 2020
View articletitled, Building on the Promise of Cancer Vaccines for Solid Tumors
Open the PDF for Building on the Promise of Cancer Vaccines for Solid Tumors in another window
Journal Articles

CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic Cancer

Alex D. Michaels, Timothy E. Newhook, Sara J. Adair, Sho Morioka, Bernadette J. Goudreau, Sarbajeet Nagdas, Matthew G. Mullen, Jesse B. Persily, Timothy N. J. Bullock, Craig L. Slingluff, Jr, Kodi S. Ravichandran, J. Thomas Parsons, Todd W. Bauer
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (6): 1415–1425.
https://doi.org/10.1158/1078-0432.CCR-17-2283
Published: 14 March 2018
View articletitled, CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic Cancer
Open the PDF for CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic Cancer in another window
Includes: Supplementary data
Journal Articles

Vaccination with Melanoma Helper Peptides Induces Antibody Responses Associated with Improved Overall Survival

Caroline M. Reed, Nicole D. Cresce, Ileana S. Mauldin, Craig L. Slingluff, Jr, Walter C. Olson
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (17): 3879–3887.
https://doi.org/10.1158/1078-0432.CCR-15-0233
Published: 31 August 2015
View articletitled, Vaccination with Melanoma Helper Peptides Induces Antibody Responses Associated with Improved Overall Survival
Open the PDF for Vaccination with Melanoma Helper Peptides Induces Antibody Responses Associated with Improved Overall Survival in another window
Includes: Supplementary data
Journal Articles

A Randomized Phase II Trial of Multiepitope Vaccination with Melanoma Peptides for Cytotoxic T Cells and Helper T Cells for Patients with Metastatic Melanoma (E1602)

Craig L. Slingluff, Jr, Sandra Lee, Fengmin Zhao, Kimberly A. Chianese-Bullock, Walter C. Olson, Lisa H. Butterfield, Theresa L. Whiteside, Philip D. Leming, John M. Kirkwood
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (15): 4228–4238.
https://doi.org/10.1158/1078-0432.CCR-13-0002
Published: 31 July 2013
View articletitled, A Randomized Phase II Trial of Multiepitope Vaccination with Melanoma Peptides for Cytotoxic T Cells and Helper T Cells for Patients with Metastatic Melanoma (E1602)
Open the PDF for A Randomized Phase II Trial of Multiepitope Vaccination with Melanoma Peptides for Cytotoxic T Cells and Helper T Cells for Patients with Metastatic Melanoma (E1602) in another window
Includes: Supplementary data
Journal Articles

Clinical Activity and Safety of Combination Therapy with Temsirolimus and Bevacizumab for Advanced Melanoma: A Phase II Trial (CTEP 7190/Mel47)

Craig L. Slingluff, Jr, Gina R. Petroni, Kerrington R. Molhoek, David L. Brautigan, Kimberly A. Chianese-Bullock, Amber L. Shada, Mark E. Smolkin, Walter C. Olson, Alison Gaucher, Cheryl Murphy Chase, William W. Grosh, Geoffrey R. Weiss, Aubrey G. Wagenseller, Anthony J. Olszanski, Lainie Martin, Sofia M. Shea, Gulsun Erdag, Prahlad Ram, Jeffrey E. Gershenwald, Michael J. Weber
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (13): 3611–3620.
https://doi.org/10.1158/1078-0432.CCR-12-3919
Published: 30 June 2013
View articletitled, Clinical Activity and Safety of Combination Therapy with Temsirolimus and Bevacizumab for Advanced Melanoma: A Phase II Trial (CTEP 7190/Mel47)
Open the PDF for Clinical Activity and Safety of Combination Therapy with Temsirolimus and Bevacizumab for Advanced Melanoma: A Phase II Trial (CTEP 7190/Mel47) in another window
Includes: Supplementary data
Journal Articles

Achieving Sufficient Accrual to Address the Primary Endpoint in Phase III Clinical Trials from U.S. Cooperative Oncology Groups

Anneke T. Schroen, Gina R. Petroni, Hongkun Wang, Monika J. Thielen, Robert Gray, Jacqueline Benedetti, Xiaofei F. Wang, Daniel J. Sargent, Donald L. Wickerham, Walter Cronin, Benjamin Djulbegovic, Craig L. Slingluff, Jr
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (1): 256–262.
https://doi.org/10.1158/1078-0432.CCR-11-1633
Published: 02 January 2012
View articletitled, Achieving Sufficient Accrual to Address the Primary Endpoint in Phase III Clinical Trials from U.S. Cooperative Oncology Groups
Open the PDF for Achieving Sufficient Accrual to Address the Primary Endpoint in Phase III Clinical Trials from U.S. Cooperative Oncology Groups in another window
Includes: Supplementary data
Journal Articles

Molecular Insights on the Peripheral and Intratumoral Effects of Systemic High-Dose rIL-2 (Aldesleukin) Administration for the Treatment of Metastatic Melanoma

Geoffrey R. Weiss, William W. Grosh, Kimberly A. Chianese-Bullock, Yingdong Zhao, Hui Liu, Craig L. Slingluff, Jr, Francesco M. Marincola, Ena Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (23): 7440–7450.
https://doi.org/10.1158/1078-0432.CCR-11-1650
Published: 30 November 2011
View articletitled, Molecular Insights on the Peripheral and Intratumoral Effects of Systemic High-Dose rIL-2 (Aldesleukin) Administration for the Treatment of Metastatic Melanoma
Open the PDF for Molecular Insights on the Peripheral and Intratumoral Effects of Systemic High-Dose rIL-2 (Aldesleukin) Administration for the Treatment of Metastatic Melanoma in another window
Journal Articles

Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers

Lisa H. Butterfield, A. Karolina Palucka, Cedrik M. Britten, Madhav V. Dhodapkar, Leif Håkansson, Sylvia Janetzki, Yutaka Kawakami, Thomas-Oliver Kleen, Peter P. Lee, Cristina Maccalli, Holden T. Maecker, Vernon C. Maino, Michele Maio, Anatoli Malyguine, Giuseppe Masucci, Graham Pawelec, Douglas M. Potter, Licia Rivoltini, Lupe G. Salazar, Dolores J. Schendel, Craig L. Slingluff, Jr, Wenru Song, David F. Stroncek, Hideaki Tahara, Magdalena Thurin, Giorgio Trinchieri, Sjoerd H. van Der Burg, Theresa L. Whiteside, Jon M. Wigginton, Francesco Marincola, Samir Khleif, Bernard A. Fox, Mary L. Disis
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (10): 3064–3076.
https://doi.org/10.1158/1078-0432.CCR-10-2234
Published: 15 May 2011
View articletitled, Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers
Open the PDF for Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers in another window
Journal Articles

Effect of Granulocyte/Macrophage Colony-Stimulating Factor on Circulating CD8+ and CD4+ T-Cell Responses to a Multipeptide Melanoma Vaccine: Outcome of a Multicenter Randomized Trial

Craig L. Slingluff, Jr., Gina R. Petroni, Walter C. Olson, Mark E. Smolkin, Merrick I. Ross, Naomi B. Haas, William W. Grosh, Marc E. Boisvert, John M. Kirkwood, Kimberly A. Chianese-Bullock
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (22): 7036–7044.
https://doi.org/10.1158/1078-0432.CCR-09-1544
Published: 11 November 2009
View articletitled, Effect of Granulocyte/Macrophage Colony-Stimulating Factor on Circulating CD8+ and CD4+ T-Cell Responses to a Multipeptide Melanoma Vaccine: Outcome of a Multicenter Randomized Trial
Open the PDF for Effect of Granulocyte/Macrophage Colony-Stimulating Factor on Circulating CD8+ and CD4+ T-Cell Responses to a Multipeptide Melanoma Vaccine: Outcome of a Multicenter Randomized Trial in another window
Includes: Supplementary data
Journal Articles

Immunologic and Clinical Outcomes of a Randomized Phase II Trial of Two Multipeptide Vaccines for Melanoma in the Adjuvant Setting

Craig L. Slingluff, Jr., Gina R. Petroni, Kimberly A. Chianese-Bullock, Mark E. Smolkin, Sarah Hibbitts, Cheryl Murphy, Naomi Johansen, William W. Grosh, Galina V. Yamshchikov, Patrice Y. Neese, James W. Patterson, Robyn Fink, Patrice K. Rehm
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (21): 6386–6395.
https://doi.org/10.1158/1078-0432.CCR-07-0486
Published: 01 November 2007
View articletitled, Immunologic and Clinical Outcomes of a Randomized Phase II Trial of Two Multipeptide Vaccines for Melanoma in the Adjuvant Setting
Open the PDF for Immunologic and Clinical Outcomes of a Randomized Phase II Trial of Two Multipeptide Vaccines for Melanoma in the Adjuvant Setting in another window
Journal Articles

Peptide and Dendritic Cell Vaccines

Craig L. Slingluff, Jr., Victor H. Engelhard, Soldano Ferrone
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (7): 2342s–2345s.
https://doi.org/10.1158/1078-0432.CCR-05-2541
Published: 11 April 2006
View articletitled, Peptide and Dendritic Cell Vaccines
Open the PDF for Peptide and Dendritic Cell Vaccines in another window
Journal Articles

Innovations and Challenges in Melanoma: Summary Statement from the First Cambridge Conference

Michael B. Atkins, David E. Elder, Richard Essner, Keith T. Flaherty, Thomas F. Gajewski, Frank G. Haluska, Patrick Hwu, Ulrich Keilholz, John M. Kirkwood, James W. Mier, Merrick I. Ross, Craig L. Slingluff, Vernon K. Sondak, Jeffrey A. Sosman, Martin A. Weinstock, Laura King
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (7): 2291s–2296s.
https://doi.org/10.1158/1078-0432.CCR-05-2560
Published: 11 April 2006
View articletitled, Innovations and Challenges in Melanoma: Summary Statement from the First Cambridge Conference
Open the PDF for Innovations and Challenges in Melanoma: Summary Statement from the First Cambridge Conference in another window
Journal Articles

Genomic Organization, Incidence, and Localization of the SPAN-X Family of Cancer-Testis Antigens in Melanoma Tumors and Cell Lines

V. Anne Westbrook, Pamela D. Schoppee, Alan B. Diekman, Kenneth L. Klotz, Margaretta Allietta, Kevin T. Hogan, Craig L. Slingluff, James W. Patterson, Henry F. Frierson, William P. Irvin, Jr., Charles J. Flickinger, Michael A. Coppola, John C. Herr
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (1): 101–112.
https://doi.org/10.1158/1078-0432.CCR-0647-3
Published: 20 January 2004
View articletitled, Genomic Organization, Incidence, and Localization of the SPAN-X Family of Cancer-Testis Antigens in Melanoma Tumors and Cell Lines
Open the PDF for Genomic Organization, Incidence, and Localization of the SPAN-X Family of Cancer-Testis Antigens in Melanoma Tumors and Cell Lines in another window
Journal Articles

MAGE-6 Encodes HLA-DRβ1*0401-presented Epitopes Recognized by CD4+ T Cells from Patients with Melanoma or Renal Cell Carcinoma

Tomohide Tatsumi, Lisa S. Kierstead, Elena Ranieri, Loreto Gesualdo, Francesco P. Schena, James H. Finke, Ronald M. Bukowski, Vladimir Brusic, John Sidney, Alessandro Sette, Theodore F. Logan, Yvette L. Kasamon, Craig L. Slingluff, Jr., John M. Kirkwood, Walter J. Storkus
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (3): 947–954.
Published: 01 March 2003
View articletitled, MAGE-6 Encodes HLA-DRβ1*0401-presented Epitopes Recognized by CD4+ T Cells from Patients with Melanoma or Renal Cell Carcinoma
Open the PDF for MAGE-6 Encodes HLA-DRβ1*0401-presented Epitopes Recognized by CD4+ T Cells from Patients with Melanoma or Renal Cell Carcinoma in another window
Journal Articles

Phase I Trial of a Melanoma Vaccine with gp100280–288 Peptide and Tetanus Helper Peptide in Adjuvant: Immunologic and Clinical Outcomes

Craig L. Slingluff, Jr., Galina Yamshchikov, Patrice Neese, Holly Galavotti, Shannon Eastham, Victor H. Engelhard, Dave Kittlesen, Donna Deacon, Sarah Hibbitts, William W. Grosh, Gina Petroni, Roger Cohen, Catie Wiernasz, James W. Patterson, Brian P. Conway, William G. Ross
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (10): 3012–3024.
Published: 01 October 2001
View articletitled, Phase I Trial of a Melanoma Vaccine with gp100280–288 Peptide and Tetanus Helper Peptide in Adjuvant: Immunologic and Clinical Outcomes
Open the PDF for Phase I Trial of a Melanoma Vaccine with gp100280–288 Peptide and Tetanus Helper Peptide in Adjuvant: Immunologic and Clinical Outcomes in another window
Journal Articles

Analysis of a Natural Immune Response against Tumor Antigens in a Melanoma Survivor: Lessons Applicable to Clinical Trial Evaluations

Galina Yamshchikov, Lee Thompson, William G. Ross, Holly Galavotti, William Aquila, Donna Deacon, Jennifer Caldwell, James W. Patterson, Donald F. Hunt, Craig L. Slingluff, Jr.
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (3): 909s–916s.
Published: 01 March 2001
View articletitled, Analysis of a Natural Immune Response against Tumor Antigens in a Melanoma Survivor: Lessons Applicable to Clinical Trial Evaluations
Open the PDF for Analysis of a Natural Immune Response against Tumor Antigens in a Melanoma Survivor: Lessons Applicable to Clinical Trial Evaluations in another window